No Data
The Analyst Landscape: 7 Takes On GoodRx Holdings
Throughout the last three months, 7 analysts have evaluated GoodRx Holdings (NASDAQ:GDRX), offering a diverse set of opinions from bullish to bearish.The table below provides a concise overview of rec
TD Cowen Maintains GoodRx(GDRX.US) With Buy Rating, Maintains Target Price $16
TD Cowen analyst Charles Rhyee maintains $GoodRx(GDRX.US)$ with a buy rating, and maintains the target price at $16.According to TipRanks data, the analyst has a success rate of 47.4% and a total aver
Morgan Stanley Maintains GoodRx(GDRX.US) With Hold Rating, Raises Target Price to $9.5
Morgan Stanley analyst Craig Hettenbach maintains $GoodRx(GDRX.US)$ with a hold rating, and adjusts the target price from $7 to $9.5.According to TipRanks data, the analyst has a success rate of 60.3%
Express News | GoodRx Holdings Inc. : Morgan Stanley Raises Target Price to $9.50 From $7.00
Express News | Morgan Stanley Maintains Equal-Weight on GoodRx Holdings, Raises Price Target to $9.5
Express News | GoodRx Holdings Inc : Guggenheim Raises Target Price to $11 From $10
Tan Chin Seng klang : must buy more apples and Nvidia